Progress in Aptamer Research and Future Applications
ChemistryOpen · 2025-07 · 14 (7)
DOI: 10.1002/open.202400463 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemistryOpen, online erschienen am 03.02.2025. Verfasst von Song Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Anzhen Hospital, Capital Medical University, Experimental Research Center, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing,…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, SELEX Aptamer Technique. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aptamers are short, single‐stranded DNA, RNA or synthetic XNA molecules that bind to target molecules with high specificity and affinity. These intrinsically structured RNA or DNA oligonucleotides are not only substitutes for antibodies, but also show great potential for applications in diagnostics, specific drug delivery, and treatment of certain diseases. While the process of aptamer identification and its core functional mechanism known as systematic evolution of exponentially enriched ligands (SELEX), SELEX involves a number of single processes, each contributing to the success or failure of aptamer generation. Today, aptamers are widely used to facilitate basic research discoveries and clinical diagnostics. In addition, aptamers play a promising role as clinical diagnostic and therapeutic agents. This review provides recent advances in this rapidly growing field of research, with special emphasis on aptamer generation and screening, small molecule aptamers, the development of aptamer applications, and applications in clinical medicine. And it also discusses the problems that still exist today with aptamers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Anzhen Hospital, Capital Medical University, Experimental Research Center, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
- Guangxi Medical University, Life Sciences Institute, Nanning, China.
ORCID-Profile: Hongfeng Jiang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., Li, X., Gao, H., Chen, J., & Jiang, H. (2025). Progress in Aptamer Research and Future Applications. ChemistryOpen, 14(7). https://doi.org/10.1002/open.202400463
Vancouver
Liu S, Li X, Gao H, Chen J, Jiang H. Progress in Aptamer Research and Future Applications. ChemistryOpen. 2025;14(7). doi:10.1002/open.202400463
BibTeX
@article{Liu2025,
author = {Liu, Song and Li, Xiaolu and Gao, Huyang and Chen, Jing and Jiang, Hongfeng},
title = {Progress in Aptamer Research and Future Applications},
journal = {ChemistryOpen},
year = {2025},
volume = {14},
number = {7},
doi = {10.1002/open.202400463}
}
EUVIMED